GlaxoSmithKlineGlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information please visit

GlaxoSmithKline RSS Channel

Title Filter      Display #  
# Article Title
1 New European consortium formed to help further advance development of a GSK/NIH Ebola candidate vaccine
2 GSK statement on first phase 1 trial results of a candidate Ebola vaccine
3 GSK commits further funding to advance bioelectronics research with creation of $5 million Innovation Challenge Fund
4 GSK joins with research councils in UK and South Africa to tackle non-communicable diseases
5 Ebola vaccine trials fast-tracked by international consortium
6 Where do you start when developing a new medicine?
7 GSK increases stake in Indian Pharmaceuticals subsidiary to 75 %
8 Tafinlar® receives FDA Breakthrough Therapy designation for non-small cell lung cancer with BRAF mutation
9 GSK adds detailed clinical trial data to multi-sponsor request system
10 GSK responds to FDA decision on Avandia (rosiglitazone)
11 H5N1 vaccine approved by the U.S. FDA as pandemic influenza preparedness measure
12 Five inspirational organisations from Malawi, Bangladesh, Mali, Kenya, and Colombia recognised by GSK and Save the Children
13 GSK names inaugural winners in unique competition for academic drug hunters
14 New partnership between GSK and the Bill & Melinda Gates Foundation to accelerate research into vaccines for global health needs
15 GSK and Genmab announce submission to US regulatory authorities for Arzerra® (ofatumumab)
16 GSK signs a multi-year agreement with BARDA to supply the US government with anthrax treatment
17 GSK launches $50 million venture capital fund to invest in pioneering bioelectronic medicines and technologies
18 GSK adds to its commitment to GAVI Alliance to help protect millions more children against infectious diseases
19 GSK announces US submission for dabrafenib/trametinib combination in metastatic melanoma
20 GSK and Save the Children launch $1 million award to discover new healthcare innovations for reducing child deaths
World Pharma News RSS Channel
Subscribe to World Pharma News by Email

Follow/Join us on:   Facebook   Twitter   XING   LinkedIn   Google Groups    FeedBurner

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]